CompoAtlas

Anrus

Natural health product licensed in Canada

Other names
Anrus Capsule
Licence holder
Nature's Ace Biopharmaceutical Inc.
NPN or DIN-HM
80107250
Status
Active licence
Licence date
12 January 2021
Revision date
Not provided
Form
Capsule, dur
Route of administration
Orale
Application type
Générale (non traditionelle)

If this product were sold in France

No point flagged by the rules we apply.

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the sourceMaximum per day, adult
Echinacea angustifolia

Source : Echinacea angustifolia - racine

Extract : Matériel brut sec

Extraction ratio : 10:1

Dry plant equivalent : 1,000 mg

100 mgNot calculated
Magnolia biondii

Source : Magnolia biondii - Fleur

Extract : Matériel brut sec

Extraction ratio : 10:1

Dry plant equivalent : 600 mg

60 mgNot calculated
Hyptis capitata

Extract : Matériel brut sec

Extraction ratio : 10:1

Dry plant equivalent : 1,000 mg

100 mgNot calculated
Forsythia suspensa

Source : Forsythia suspensa - fruit

Extract : Matériel brut sec

Extraction ratio : 10:1

Dry plant equivalent : 1,200 mg

120 mgNot calculated
Scutellaria baicalensis

Extract : Matériel brut sec

Extraction ratio : 10:1

Dry plant equivalent : 800 mg

80 mgNot calculated

Non-medicinal ingredients

Dioxyde de silicium, Stéarate de magnésium, Hydroxypropyl méthylcellulose

PopulationAgeQuantity per servingFrequency
Adultesminimum: 18 years1 Capsule1 Tous les jours

Uses authorised in Canada

Text supplied in English because no French text is available.

Echinacea Angustifolia is traditionally used in Herbal Medicine to help relieve the symptoms of upper respiratory tract infections.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

No French warning text available in the imported data.

Warnings are available in English on the official record.

Source

Official Health Canada record, licence 80107250

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Enter to analyse, Shift+Enter for a new line